These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 7720815)

  • 1. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
    Strømhaug A; Warren DJ; Slørdal L
    Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a reversible block in murine CFU-C differentiation by exposure to nitrous oxide.
    Warren DJ; Slørdal L
    Exp Hematol; 1993 Feb; 21(2):345-9. PubMed ID: 8425570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM; Zaharko DS; Bull JM; Chabner BA
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.
    Petzer AL; Geisen FH; Bilgeri R; Zilian U; Haun M; Herold M; Braunsteiner H; Konwalinka G
    Exp Hematol; 1995 Jun; 23(6):529-34. PubMed ID: 7539380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
    Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
    Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin II on hematopoietic progenitor cell proliferation.
    Rodgers KE; Xiong S; Steer R; diZerega GS
    Stem Cells; 2000; 18(4):287-94. PubMed ID: 10924095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine CFU-C by vindesine: restoration of colony growth by colony stimulating factor.
    Pigoli G; Mangoni L; Caramatti C; Degliantoni G; Rizzoli V
    Int J Cell Cloning; 1983 Jul; 1(3):142-50. PubMed ID: 6609213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures.
    Giuliani N; Girasole G; Vescovi PP; Passeri G; Pedrazzoni M
    Alcohol Clin Exp Res; 1999 Feb; 23(2):381-5. PubMed ID: 10069572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
    Naparstek E; Ohana M; Greenberger JS; Slavin S
    Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
    Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
    J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture and characterization of hematopoietic progenitor cells from miniature swine.
    Emery DW; Sachs DH; LeGuern C
    Exp Hematol; 1996 Jul; 24(8):927-35. PubMed ID: 8690052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
    Pinedo HM; Zaharko DS; Bull J; Chabner BA
    Cancer Res; 1977 Feb; 37(2):445-50. PubMed ID: 832268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditions that support long-term production of osteoclast progenitors in vitro.
    Lee MY; Fevold KL; Muguruma Y; Lottsfeldt JL
    Stem Cells; 1997; 15(5):340-6. PubMed ID: 9323795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.